These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21345510)

  • 21. Influence of multiple genetic polymorphisms on genitourinary morbidity after carbon ion radiotherapy for prostate cancer.
    Suga T; Iwakawa M; Tsuji H; Ishikawa H; Oda E; Noda S; Otsuka Y; Ishikawa A; Ishikawa K; Shimazaki J; Mizoe JE; Tsujii H; Imai T
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):808-13. PubMed ID: 18374504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. To bleed or not to bleed. A prediction based on individual gene profiling combined with dose-volume histogram shapes in prostate cancer patients undergoing three-dimensional conformal radiation therapy.
    Valdagni R; Rancati T; Ghilotti M; Cozzarini C; Vavassori V; Fellin G; Fiorino C; Girelli G; Barra S; Zaffaroni N; Pierotti MA; Gariboldi M
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1431-40. PubMed ID: 19211196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate cancer: biological dose considerations and constraints in tele- and brachytherapy.
    Dörr W; Jaal J; Zips D
    Strahlenther Onkol; 2007 Dec; 183 Spec No 2():14-5. PubMed ID: 18166999
    [No Abstract]   [Full Text] [Related]  

  • 24. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio.
    Hille A; Töws N; Schmidberger H; Hess CF
    Strahlenther Onkol; 2005 Dec; 181(12):789-95. PubMed ID: 16362789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-course, intensity-modulated radiotherapy for localized prostate cancer.
    Kupelian PA; Willoughby TR
    Cancer J; 2001; 7(5):421-6. PubMed ID: 11693901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of amino acid substitution variants of DNA repair genes in radiosusceptibility of cervical cancer patients; a pilot study.
    Farkasova T; Gurska S; Witkovsky V; Gabelova A
    Neoplasma; 2008; 55(4):330-7. PubMed ID: 18505345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dosimetric factors predictive of late toxicity in prostate cancer radiotherapy].
    de Crevoisier R; Fiorino C; Dubray B
    Cancer Radiother; 2010 Oct; 14(6-7):460-8. PubMed ID: 20797890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer.
    Peeters ST; Hoogeman MS; Heemsbergen WD; Slot A; Tabak H; Koper PC; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1142-52. PubMed ID: 15939547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-dimensional conformal radiotherapy for early stage prostatic cancer: techniques, outcomes, and possible pitfalls.
    Dipetrillo TA
    Surg Oncol Clin N Am; 2000 Jul; 9(3):435-53, viii. PubMed ID: 10853135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bladder and rectal toxicity of BeamCath application in radiotherapy of prostate cancer.
    Hanssen S; Norum J
    Anticancer Res; 2008; 28(5B):2865-8. PubMed ID: 19031926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment.
    Gauthier I; Carrier JF; Béliveau-Nadeau D; Fortin B; Taussky D
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1128-33. PubMed ID: 19147306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time course of late rectal toxicity after radiation therapy for prostate cancer.
    Odrazka K; Dolezel M; Vanasek J; Vaculikova M; Zouhar M; Sefrova J; Paluska P; Vosmik M; Kohlova T; Kolarova I; Macingova Z; Navratil P; Brodak M; Prosvic P
    Prostate Cancer Prostatic Dis; 2010 Jun; 13(2):138-43. PubMed ID: 20038960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic conformal arc radiotherapy with rectum hollow-out technique for localized prostate cancer.
    Tomita N; Kodaira T; Tachibana H; Nakamura T; Tomoda T; Nakahara R; Inokuchi H; Hayashi N; Fuwa N
    Radiother Oncol; 2009 Mar; 90(3):346-52. PubMed ID: 18950880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA repair capacity and acute radiotherapy adverse effects in Italian breast cancer patients.
    Sterpone S; Cornetta T; Padua L; Mastellone V; Giammarino D; Testa A; Tirindelli D; Cozzi R; Donato V
    Mutat Res; 2010 Feb; 684(1-2):43-8. PubMed ID: 19962393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM--a study based on DNA from formalin fixed paraffin embedded tissue samples.
    Andreassen CN; Alsner J; Overgaard M; Sørensen FB; Overgaard J
    Int J Radiat Biol; 2006 Aug; 82(8):577-86. PubMed ID: 16966185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
    Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
    J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Constitutive mRNA expression of DNA repair-related genes as a biomarker for clinical radio-resistance: A pilot study in prostate cancer patients receiving radiotherapy.
    Hümmerich J; Werle-Schneider G; Popanda O; Celebi O; Chang-Claude J; Kropp S; Mayer C; Debus J; Bartsch H; Schmezer P
    Int J Radiat Biol; 2006 Aug; 82(8):593-604. PubMed ID: 16966187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does pelvic lymph nodes irradiation using intensity modulated radiation therapy increase rectal and bladder toxicities in patients with prostate carcinoma?
    Garipagaoglu M; Sengoz M; Senkesen O; Ozan Göksel E; Tezcanli E; Kucucuk H; Aslay I
    J BUON; 2010; 15(4):668-73. PubMed ID: 21229627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A method for the prediction of late organ-at-risk toxicity after radiotherapy of the prostate using equivalent uniform dose.
    Fleming C; Kelly C; Thirion P; Fitzpatrick K; Armstrong J
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):608-13. PubMed ID: 20934261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.